Your browser doesn't support javascript.
loading
Biological Activity of the Carrier as a Factor in Immunogen Design for Haptens.
Ertekin, Özlem; Akçael, Esin; Kocaaga, Harun; Öztürk, Selma.
Afiliação
  • Ertekin Ö; TÜBITAK, The Scientific and Technological Research Council of Turkey, Marmara Research Center, Genetic Engineering and Biotechnology Institute, 41470 Gebze, Kocaeli, Turkey. ozlem.ertekin@gmail.com.
  • Akçael E; TÜBITAK, The Scientific and Technological Research Council of Turkey, Marmara Research Center, Genetic Engineering and Biotechnology Institute, 41470 Gebze, Kocaeli, Turkey. esin.akcael@tubitak.gov.tr.
  • Kocaaga H; TÜBITAK, The Scientific and Technological Research Council of Turkey, Marmara Research Center, Genetic Engineering and Biotechnology Institute, 41470 Gebze, Kocaeli, Turkey. harun.kocaaga@tubitak.gov.tr.
  • Öztürk S; TÜBITAK, The Scientific and Technological Research Council of Turkey, Marmara Research Center, Genetic Engineering and Biotechnology Institute, 41470 Gebze, Kocaeli, Turkey. selma.ozturk@tubitak.gov.tr.
Molecules ; 23(11)2018 Nov 14.
Article em En | MEDLINE | ID: mdl-30441861
ABSTRACT
Immunoanalytical methods are frequently employed in the detection of hazardous small molecular weight compounds. However, antibody development for these molecules is a challenge, because they are haptens and cannot induce a humoral immune response in experimental animals. Immunogenic forms of haptens are usually prepared by conjugating them to a protein carrier which serves as an immune stimulator. However, the carrier is usually considered merely as a bulk mass, and its biological activity is ignored. Here, we induced an endocytic receptor, transferrin receptor, by selecting its ligand as a carrier protein to enhance antibody production. We conjugated aflatoxin, a potent carcinogenic food contaminant, to transferrin and evaluated its potential to stimulate antibody production with respect to ovalbumin conjugates. Transferrin conjugates induced aflatoxin-specific immune responses in the second immunization, while ovalbumin conjugates reached similar antibody titers after 5 injections. Monoclonal antibodies were successfully developed with mice immunized with either of the conjugates.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas de Transporte / Haptenos Limite: Animals / Humans Idioma: En Revista: Molecules Assunto da revista: BIOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Turquia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas de Transporte / Haptenos Limite: Animals / Humans Idioma: En Revista: Molecules Assunto da revista: BIOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Turquia